about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorep...
Read More
54.40
0.68
(1.27%)
828.3K
XNAS Volume
XNAS 08 Jun, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Cg Oncology Inc is scheduled for today, for the purpose of Goldman Sachs 47th Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cg Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..